These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


233 related items for PubMed ID: 1873590

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Varicella zoster infection after bone marrow transplantation: incidence, risk factors and complications.
    Han CS, Miller W, Haake R, Weisdorf D.
    Bone Marrow Transplant; 1994 Mar; 13(3):277-83. PubMed ID: 8199570
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Analysis of varicella zoster virus infection following allogeneic stem cell transplants].
    Doki N, Hoshino T, Irisawa H, Sakura T, Miyawaki S.
    Rinsho Ketsueki; 2004 Oct; 45(10):1090-4. PubMed ID: 15553042
    [Abstract] [Full Text] [Related]

  • 6. Varicella-zoster virus infections after autologous bone marrow transplantation in children.
    Wacker P, Hartmann O, Benhamou E, Salloum E, Lemerle J.
    Bone Marrow Transplant; 1989 Mar; 4(2):191-4. PubMed ID: 2650789
    [Abstract] [Full Text] [Related]

  • 7. Factors influencing varicella zoster virus infection after allogeneic peripheral blood stem cell transplantation: low-dose acyclovir prophylaxis and pre-transplant diagnosis of lymphoproliferative disorders.
    Kim DH, Messner H, Minden M, Gupta V, Kuruvilla J, Wright J, Lipton J.
    Transpl Infect Dis; 2008 Apr; 10(2):90-8. PubMed ID: 17605742
    [Abstract] [Full Text] [Related]

  • 8. Visceral varicella-zoster after bone marrow transplantation: report of a case series and review of the literature.
    David DS, Tegtmeier BR, O'Donnell MR, Paz IB, McCarty TM.
    Am J Gastroenterol; 1998 May; 93(5):810-3. PubMed ID: 9625133
    [Abstract] [Full Text] [Related]

  • 9. Long-term acyclovir prophylaxis for prevention of varicella zoster virus infection after autologous blood stem cell transplantation in patients with acute leukemia.
    Sempere A, Sanz GF, Senent L, de la Rubia J, Jarque I, López F, Arilla MJ, Guinot M, Martín G, Martínez J.
    Bone Marrow Transplant; 1992 Dec; 10(6):495-8. PubMed ID: 1362686
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [The frequency and risk factor of herpes zoster infection in non-Hodgkin's lymphoma patients].
    Usami E, Kimura M, Matsuoka T, Okada K, Nakao T, Yoshimura T, Yasuda T.
    Gan To Kagaku Ryoho; 2011 Feb; 38(2):243-7. PubMed ID: 21368488
    [Abstract] [Full Text] [Related]

  • 13. Autologous bone marrow transplantation following high-dose busulfan and VP-16 for advanced non-Hodgkin's lymphoma and Hodgkin's disease.
    Rosenfeld CS, Przepiorka D, Schwinghammer TL, Buck DS, Bloom EJ, Shadduck RK.
    Exp Hematol; 1991 Jun; 19(5):317-21. PubMed ID: 2026183
    [Abstract] [Full Text] [Related]

  • 14. Varicella-zoster virus disease is more frequent after cord blood than after bone marrow transplantation.
    Vandenbosch K, Ovetchkine P, Champagne MA, Haddad E, Alexandrov L, Duval M.
    Biol Blood Marrow Transplant; 2008 Aug; 14(8):867-71. PubMed ID: 18640569
    [Abstract] [Full Text] [Related]

  • 15. Varicella zoster virus infection associated with high-dose chemotherapy and autologous stem-cell rescue.
    Bilgrami S, Chakraborty NG, Rodriguez-Pinero F, Khan AM, Feingold JM, Bona RD, Edwards RL, Dorsky D, Clive J, Mukherji B, Tutschka PJ.
    Bone Marrow Transplant; 1999 Mar; 23(5):469-74. PubMed ID: 10100561
    [Abstract] [Full Text] [Related]

  • 16. [Infections due to herpes-varicella viruses in Hodgkin's disease (author's transl)].
    Redón J, Herranz C, Montalar J, Navarro JR, Blanes A, Munarriz B, Reynés G, Caballero M.
    Med Clin (Barc); 1981 May 10; 76(9):377-80. PubMed ID: 6264237
    [Abstract] [Full Text] [Related]

  • 17. The treatment of relapsed or refractory intermediate grade non-Hodgkin's lymphoma with autologous bone marrow transplantation followed by cyclosporine and interferon.
    Gryn J, Johnson E, Goldman N, Devereux L, Grana G, Hageboutros A, Fernandez E, Constantinou C, Harrer W, Viner E, Goldberg J.
    Bone Marrow Transplant; 1997 Feb 10; 19(3):221-6. PubMed ID: 9028549
    [Abstract] [Full Text] [Related]

  • 18. Incidence, risk factors and outcome of varicella-zoster virus infection in children after haematopoietic stem cell transplantation.
    Leung TF, Chik KW, Li CK, Lai H, Shing MM, Chan PK, Lee V, Yuen PM.
    Bone Marrow Transplant; 2000 Jan 10; 25(2):167-72. PubMed ID: 10673675
    [Abstract] [Full Text] [Related]

  • 19. Phase I/II study of high-dose cyclophosphamide, etoposide and cisplatin followed by autologous bone marrow or peripheral blood stem cell transplantation in patients with poor prognosis Hodgkin's disease or non-Hodgkin's lymphoma.
    Klumpp TR, Mangan KF, Glenn LD, Malaspina DR, Cropper T, Mullaney M, Macdonald JS.
    Bone Marrow Transplant; 1993 Oct 10; 12(4):337-45. PubMed ID: 7506091
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.